What Does It Take To Be A Biologics CDMO That Can Serve Today's Mammalian Clinical Manufacturing Needs?

By Abby Sorensen, Marketing Manager, Scorpius BioManufacturing

Launching a novel biologic therapeutic is fraught with challenges, especially navigating the complexities of clinical manufacturing. Finding a trusted CDMO partner capable of guiding emerging biotechs throughout their product’s lifecycle and accelerating time to market is crucial for maximizing the potential success of your novel therapeutic.

Scorpius BioManufacturing specializes in mammalian clinical manufacturing, crafting monoclonal antibodies, bispecifics, and recombinant proteins with meticulous precision. Our cutting-edge facility, built around the power of single-use systems, eliminates contamination risks and streamlines production, ensuring faster changeovers and greater flexibility.

But our true advantage lies in our people. Decades of industry experience flow through our veins, guiding your project with data-driven decisions and unwavering collaboration. We work hand-in-hand with you, upstream and downstream, optimizing processes, maximizing yield, and minimizing your cost of goods.

Brian O'Mara, Senior Director of Manufacturing, Sciences & Technology at Scorpius BioManufacturing, discusses Scorpius’ mammalian clinical manufacturing capabilities and how to overcome manufacturing challenges as companies attempt to scale their programs.